CASP3 and lung carcinoma: This difference in sensitivity and responsiveness was also manifested mechanistically as demonstrated in the ability of violacein to promote apoptotic cell death by upregulating cleaved PARP, a downstream target of the effector pro-apoptotic molecule caspase 3, in brain and lung cancer cells.